1-5 of 5
Jan Davis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia

Clinical Trials & Observations
Hagop Kantarjian, Yasuhiro Oki, Guillermo Garcia-Manero, Xuelin Huang, Susan O'Brien, Jorge Cortes, Stefan Faderl, Carlos Bueso-Ramos, Farhad Ravandi, Zeev Estrov, Alessandra Ferrajoli, William Wierda, Jianqin Shan, Jan Davis, Francis Giles, Hussain I. Saba, Jean-Pierre J. Issa
Journal: Blood
Blood (2006) 109 (1): 52–57.
https://doi.org/10.1182/blood-2006-05-021162
Published: 2006
Journal Articles

Final Results of a Phase I Study of the Histone Deacetylase Inhibitor Vorinostat (Suberoyanilide Hydroxamic Acid, SAHA), in Patients with Leukemia and Myelodysplastic Syndrome.

Guillermo Garcia-Manero, MD, Hui Yang, MD, PhD, Blanca Sanchez-Gonzalez, MD, Srdan Verstovsek, MD, Alessandra Ferrajoli, MD, Michael Keating, MD, Michael Andreeff, MD, Susan O’Brien, MD, Jorge Cortes, MD, William Wierda, MD, PhD, Stefan Faderl, MD, Charles Koller, MD, Jan Davis, RN, Gail Morris, RN, Jean-Pierre Issa, MD, Stanley R. Frankel, MD, Victoria Richon, PhD, Bernard Fine, PhD, Hagop Kantarjian, MD
Journal: Blood
Blood (2005) 106 (11): 2801.
https://doi.org/10.1182/blood.V106.11.2801.2801
Published: 2005
Journal Articles

Decitabine Low-Dose Schedule (100 mg/m 2 /Course) in Myelodysplastic Syndrome (MDS). Comparison of 3 Different Dose Schedules.

Hagop Kantarjian, MD, Susan O’Brien, MD, Francis Giles, MD, Farhad Ravandi-Kashani, MD, Stefan Faderl, MD, Guillermo Garcia-Manero, MD, Jan Davis, BS, ADN, Jean-Pierre Issa, MD
Journal: Blood
Blood (2005) 106 (11): 2522.
https://doi.org/10.1182/blood.V106.11.2522.2522
Published: 2005
Journal Articles

Decitabine Low-Dose Schedule (100 mg/m 2 /course) in Myelodysplastic Syndrome (MDS). Comparison of 3 Different Dose Schedules.

Hagop M. Kantarjian, MD, Farhad Ravandi, MD, Susan O’Brien, MD, Francis Giles, MD, Stefan Faderl, MD, Guillermo Garcia-Manero, MD, Jan Davis, Elihu Estey, MD, Jean-Pierre Issa.
Journal: Blood
Blood (2004) 104 (11): 1437.
https://doi.org/10.1182/blood.V104.11.1437.1437
Published: 2004
Journal Articles

Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia

Clinical Trials & Observations
Hagop Kantarjian, Varsha Gandhi, Jorge Cortes, Srdan Verstovsek, Min Du, Guillermo Garcia-Manero, Francis Giles, Stefan Faderl, Susan O'Brien, Sima Jeha, Jan Davis, Zeev Shaked, Adam Craig, Michael Keating, William Plunkett, Emil J Freireich
Journal: Blood
Blood (2003) 102 (7): 2379–2386.
https://doi.org/10.1182/blood-2003-03-0925
Published: 2003